FEB 20, 2019 03:00 PM PST

Possible New Drug To Combat African Sleeping Sickness

WRITTEN BY: Nouran Amin

Scientists have teamed up to combat African sleeping sickness, which is caused by trypanosomes, unicellular protozoans transmitted by the bite of an infected tsetse fly. They specifically discovered how an inhibitory substance docks on the parasite to deactivate one of its vital proteins. "There is still a long way to go before we arrive at a pharmaceutical product," says Professor Ute Hellmich of Johannes Gutenberg University Mainz (JGU). "But our highly interdisciplinary work involving parasitology, theoretical and organic chemistry, structural biology, and biochemistry has shown how the parasite that causes sleeping sickness can be rendered harmless."

African sleeping sickness affected about 15,000 in 2014. It is challenging to differentiate the infection from malaria as they both have similar symptoms in the early stages. "Not only the poorest people in sub-Saharan Africa are threatened, but also their cattle, which are affected on a dramatic scale by certain species of Trypanosoma brucei," explained biochemist Professor Ute Hellmich.

Learn more:

As of now, only a handful of drugs seek to treat the sleeping sickness, which is fatal if untreated. However, even though new drugs are in development, the approach in the new study goes one step further: "Our inhibitor opens up the future prospect of being able to design inhibitors on a fundamental level and could thus possibly also be used in the treatment of infection with other, related pathogenic parasites, such as Leishmania," says lead author, Annika Wagner.

"We were astonished and initially thought it was a chance effect due to experimental conditions," said Hellmich. "Instead, we took a second look at the result and then discussed it with experts from different fields. Research only progresses when we work together."

Source: Johannes Gutenberg Universitaet Mainz

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 11, 2019
Drug Discovery
JAN 11, 2019
Histamine Improves Long-Term Memory
A recent research study found that histamine could improve people’s long-term memory which may be a prospective treatment option to alleviate symptom...
JAN 14, 2019
Drug Discovery
JAN 14, 2019
Vitamin D Proved Non-Beneficial for Individuals Aged 70 and Over
According to a study in the American Journal of Clinical Nutrition, researchers at Newcastle University have confirmed that older individuals, over the age...
JAN 17, 2019
Microbiology
JAN 17, 2019
Ulcerative Colitis Relieved by Fecal Microbiota Transplant
The community of microbes in our gut is critical to our health. If it's out of balance, researchers are investigating whether 'healthy' fecal material can restore it....
FEB 20, 2019
Drug Discovery
FEB 20, 2019
Cocktail of Common Antibiotics Fights E. coli Infections
Researchers at the Technical University of Denmark are working towards finding new methods for battling antibiotic resistant bacteria. Currently, many dise...
FEB 25, 2019
Drug Discovery
FEB 25, 2019
ADHD Drug Holds No Effect on Primate Prefrontal Cortex
According to a new research study published eNeuro, investigations of methylphenidate (Ritalin) on neuronal activity in monkeys held no effects on the pref...
MAR 03, 2019
Drug Discovery
MAR 03, 2019
Drug Reverses Effects of Alcohol on the Brain
Recently, researchers have identified a drug that could help reverse the damaging effects of heavy alcohol consumption on the regeneration of neurons (brai...
Loading Comments...